Potentiation of IL-2-induced T-cell proliferation by retinoids

https://doi.org/10.1016/0192-0561(92)90031-FGet rights and content

Abstract

We evaluated the capacity of retinoids to potentiate proliferative responses of murine T-cells to recombinant human interleukin 2 (rIL-2). Concanavalin A (Con A) prestimulated spleen cells responded in a dose-dependent manner to added rIL-2. All-trans-retinoic acid (RA) at 10−8 M potentiated the proliferative response by fivefold at saturating levels of IL-2. In similar experiments, two closely related retinamides, all-trans-(phenyl)retinamide (PR) and N-(4-hydroxyphenyl)retinamide (4-HPR), also potentiated murine splenocyte rIL-2 responses. Potentiation of IL-2-induced proliferation was dose-responsive to the concentration of added retinoid with peak potentiation occurring at 10−10 − 10−8 M in the presence of 10 U/ml rIL-2. Significant potentiation was observed at retinoid concentrations as low as 10−14 M. Fluorescence flow cytomety of the responding cells revealed that among L3T4+, Lyt-2+ or total T-cells, at 72 h following Con A stimulation, essentially all of the cells expressed IL-2 receptors (IL-2R). This apparently represents near maximum IL-2R expression and treatment of the cells with retinoids did not increase IL-2R expression at that time point. The potentiation of IL-2 responses by retinoids was also observed with IL-2-dependent HT-2 cells, 98% of which were IL-2R positive. HT-2 proliferative responses to rIL-2 were potentiated as much as fourfold by 10−10 M RA. HT-2 proliferative responses to rIL-2 were potentiated by all three retinoids dose dependently. Significant potentiation was observed with as little as 10−14 M retinoid. Retinoids in the absence of IL-2 induced no proliferative responses. These data suggest that retinoids can augment the capacity of IL-2 to induce T-cell proliferation using Con A-activated murine splenic T-cell blasts and a long-term-cultured T-cell line.

References (43)

  • J.D. Ashwell et al.

    Proliferation of T lymphocytes in response to interleukin 2 varies with thier state of activation

    J. Immun.

    (1986)
  • J.E. Blalock et al.

    Retinoic acid (vitamin A acid) induced transcriptional control of interferon production

  • W. Bollag

    New retinoids with potential use in humans

  • B.E. Cohen et al.

    Vitamin A: adjuvant and steroid antagonist in the immune response

    J. Immun.

    (1973)
  • G. Dennert

    Immunostimulation by retinoids

  • G. Dennert et al.

    Effects of retinoic acid on the immune system: stimulation of T killer cell induction

    Eur. J. Immun.

    (1978)
  • D.L. Dillehay et al.

    Inhibition of Moloney murine lymphoma and sarcoma growth in vivo by dietary retinoids

    Cancer Res.

    (1989)
  • D.L. Dillehay et al.

    Effects of retinoids on macrophage function and IL-1 activity

    J. Leukocyte Biol.

    (1988)
  • S.A. Eccles et al.

    Inhibition of growth and spontaneous metastasis of transplantable tumors by an aromatic retinoic acid analogue

    Cancer Immun. Immunother.

    (1985)
  • M.P. Everson et al.

    Enhancement of IL-2-induced T cell proliferation by a novel factor(s) present in murine spleen dentritic cell-T cell culture supernatants

    J. Immun.

    (1989)
  • R. Fernandez-Botran et al.

    Lymphokine-mediated regulation of the proliferative response of clones of Th1 and Th2 cells

    J. exp. Med.

    (1988)
  • Cited by (22)

    • Immunomodulatory effects of tretinoin in combination with clindamycin

      1998, Journal of the European Academy of Dermatology and Venereology
    View all citing articles on Scopus

    This work was supported by Veterans Administration Medical Research, Grants P01-CA-34968 and R01-CA-38008 from the National Institutes of Health.

    View full text